Ronald B. DeMattos

12.9k total citations · 4 hit papers
71 papers, 9.4k citations indexed

About

Ronald B. DeMattos is a scholar working on Physiology, Molecular Biology and Pharmacology. According to data from OpenAlex, Ronald B. DeMattos has authored 71 papers receiving a total of 9.4k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Physiology, 35 papers in Molecular Biology and 11 papers in Pharmacology. Recurrent topics in Ronald B. DeMattos's work include Alzheimer's disease research and treatments (54 papers), Computational Drug Discovery Methods (11 papers) and Cholinesterase and Neurodegenerative Diseases (11 papers). Ronald B. DeMattos is often cited by papers focused on Alzheimer's disease research and treatments (54 papers), Computational Drug Discovery Methods (11 papers) and Cholinesterase and Neurodegenerative Diseases (11 papers). Ronald B. DeMattos collaborates with scholars based in United States, United Kingdom and Japan. Ronald B. DeMattos's co-authors include David M. Holtzman, Steven M. Paul, Kelly R. Bales, David J. Cummins, Jean‐Cosme Dodart, Maia Parsadanian, Mark Odell, John R. Cirrito, Patrick C. May and Jennie Taylor and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Ronald B. DeMattos

71 papers receiving 9.2k citations

Hit Papers

Peripheral anti-Aβ antibo... 2001 2026 2009 2017 2001 2011 2002 2016 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ronald B. DeMattos United States 39 6.8k 3.1k 2.4k 1.7k 1.4k 71 9.4k
Mary Jo LaDu United States 51 7.1k 1.0× 3.8k 1.2× 1.9k 0.8× 1.3k 0.8× 962 0.7× 105 9.6k
Christopher B. Eckman United States 50 9.3k 1.4× 5.9k 1.9× 1.5k 0.6× 2.4k 1.4× 1.6k 1.1× 78 12.6k
Marc Mercken Belgium 44 7.9k 1.2× 4.3k 1.4× 1.6k 0.7× 1.9k 1.1× 1.3k 0.9× 102 10.8k
G. William Rebeck United States 62 6.8k 1.0× 4.4k 1.4× 1.8k 0.8× 926 0.5× 607 0.4× 138 11.2k
Mikio Shoji Japan 55 7.0k 1.0× 5.5k 1.8× 1.8k 0.8× 1.4k 0.8× 820 0.6× 293 12.0k
Linda H. Younkin United States 44 9.2k 1.4× 4.6k 1.5× 2.5k 1.1× 2.1k 1.2× 1.3k 1.0× 72 12.1k
Pritam Das United States 41 4.7k 0.7× 2.4k 0.8× 2.3k 1.0× 1.3k 0.8× 944 0.7× 80 7.5k
Ganesh M. Shankar United States 28 8.1k 1.2× 3.9k 1.3× 1.8k 0.8× 2.2k 1.3× 1.3k 0.9× 87 11.2k
Paul M. Mathews United States 53 7.5k 1.1× 4.5k 1.4× 2.4k 1.0× 1.5k 0.9× 863 0.6× 106 11.3k
Jochen Walter Germany 60 6.0k 0.9× 5.3k 1.7× 2.3k 1.0× 1.5k 0.9× 740 0.5× 148 11.6k

Countries citing papers authored by Ronald B. DeMattos

Since Specialization
Citations

This map shows the geographic impact of Ronald B. DeMattos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald B. DeMattos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald B. DeMattos more than expected).

Fields of papers citing papers by Ronald B. DeMattos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald B. DeMattos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald B. DeMattos. The network helps show where Ronald B. DeMattos may publish in the future.

Co-authorship network of co-authors of Ronald B. DeMattos

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald B. DeMattos. A scholar is included among the top collaborators of Ronald B. DeMattos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald B. DeMattos. Ronald B. DeMattos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Salloway, Stephen, Kumar Budur, Ronald B. DeMattos, et al.. (2020). Advancing combination therapy for Alzheimer's disease. Alzheimer s & Dementia Translational Research & Clinical Interventions. 6(1). e12073–e12073. 42 indexed citations
2.
Wang, Yaming, Tyler K. Ulland, Jason D. Ulrich, et al.. (2016). TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques. The Journal of Experimental Medicine. 213(5). 667–675. 571 indexed citations breakdown →
3.
Hendrix, James A., Randall J. Bateman, H. Robert Brashear, et al.. (2016). Challenges, solutions, and recommendations for Alzheimer's disease combination therapy. Alzheimer s & Dementia. 12(5). 623–630. 38 indexed citations
4.
Portelius, Erik, Robert A. Dean, Ulf Andréasson, et al.. (2014). β-site amyloid precursor protein-cleaving enzyme 1(BACE1) inhibitor treatment induces Aβ5-X peptides through alternative amyloid precursor protein cleavage. Alzheimer s Research & Therapy. 6(5-8). 75–75. 29 indexed citations
5.
DeMattos, Ronald B., Patrick C. May, Margaret M. Racke, et al.. (2014). O1‐10‐03: COMBINATION THERAPY WITH A PLAQUE‐SPECIFIC ABETA ANTIBODY AND BACE INHIBITOR RESULTS IN DRAMATIC PLAQUE LOWERING IN AGED PDAPP TRANSGENIC MICE. Alzheimer s & Dementia. 10(4S_Part_1). 6 indexed citations
6.
Shah, Nilay S., Jean‐Sébastien Vidal, Kamal Masaki, et al.. (2012). Midlife Blood Pressure, Plasma β-Amyloid, and the Risk for Alzheimer Disease. Hypertension. 59(4). 780–786. 171 indexed citations
7.
DeMattos, Ronald B., Jirong Lu, Ying Tang, et al.. (2012). A Plaque-Specific Antibody Clears Existing β-amyloid Plaques in Alzheimer's Disease Mice. Neuron. 76(5). 908–920. 276 indexed citations
8.
Castellano, Joseph M., Jungsu Kim, Floy R. Stewart, et al.. (2011). Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance. Science Translational Medicine. 3(89). 89ra57–89ra57. 887 indexed citations breakdown →
9.
Burgess, Braydon L., Margaret M. Racke, Veronica Hirsch‐Reinshagen, et al.. (2008). ABCG1 influences the brain cholesterol biosynthetic pathway but does not affect amyloid precursor protein or apolipoprotein E metabolism in vivo. Journal of Lipid Research. 49(6). 1254–1267. 52 indexed citations
10.
Tansley, Gavin, Braydon L. Burgess, Su Yuan, et al.. (2007). The cholesterol transporter ABCG1 modulates the subcellular distribution and proteolytic processing of β-amyloid precursor protein. Journal of Lipid Research. 48(5). 1022–1034. 46 indexed citations
11.
Cao, Guoqing, Kelly R. Bales, Ronald B. DeMattos, & Steven M. Paul. (2007). Liver X Receptor-Mediated Gene Regulation and Cholesterol Homeostasis in Brain: Relevance to Alzheimers Disease Therapeutics. Current Alzheimer Research. 4(2). 179–184. 63 indexed citations
12.
DeMattos, Ronald B., et al.. (2006). P4–246: Passive immunotherapy with M266 results in altered CSF Aβ. Alzheimer s & Dementia. 2(3S_Part_19). 1 indexed citations
13.
Legleiter, Justin, Ronald B. DeMattos, David M. Holtzman, & Tomasz Kowalewski. (2004). In situ AFM studies of astrocyte-secreted apolipoprotein E- and J-containing lipoproteins. Journal of Colloid and Interface Science. 278(1). 96–106. 30 indexed citations
14.
Yu, Liang, Suizhen Lin, Thomas P. Beyer, et al.. (2004). A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes. Journal of Neurochemistry. 88(3). 623–634. 135 indexed citations
15.
Cirrito, John R., Patrick C. May, Mark Odell, et al.. (2003). In VivoAssessment of Brain Interstitial Fluid with Microdialysis Reveals Plaque-Associated Changes in Amyloid-β Metabolism and Half-Life. Journal of Neuroscience. 23(26). 8844–8853. 321 indexed citations
16.
Dodart, Jean‐Cosme, Kelly R. Bales, Kimberley S. Gannon, et al.. (2002). Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease model. Nature Neuroscience. 5(5). 452–457. 705 indexed citations breakdown →
17.
DeMattos, Ronald B., Robert P. Brendza, John E. Heuser, et al.. (2001). Purification and characterization of astrocyte-secreted apolipoprotein E and J-containing lipoproteins from wild-type and human apoE transgenic mice. Neurochemistry International. 39(5-6). 415–425. 137 indexed citations
19.
DeMattos, Ronald B., Linda K. Curtiss, & David L. Williams. (1998). A Minimally Lipidated Form of Cell-derived Apolipoprotein E Exhibits Isoform-specific Stimulation of Neurite Outgrowth in the Absence of Exogenous Lipids or Lipoproteins. Journal of Biological Chemistry. 273(7). 4206–4212. 108 indexed citations
20.
Rea, Thomas J., Ronald B. DeMattos, Reynold Homan, Roger S. Newton, & Michael E. Pape. (1996). Lack of correlation between ACAT mRNA expression and cholesterol esterification in primary liver cells. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1299(1). 67–74. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026